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Objectives: To evaluate the anaesthetic properties and tolerance of articaine versus lidocaine at equal vasocon-
strictor concentration. 
Study Design: A total of 96 male and female patients who underwent surgical treatment of the lower third molar 
participated. Patients were randomly assigned to articaine hydrochloride with epinephrine 1:100,000 and lido-
caine hydrochloride with epinephrine 1:100,000. The variables analysed were latency period, duration of anaes-
thetic effect, tolerance and adverse reactions. 
Results: Both the latency period and the duration of anaesthetic effect were greater for articaine, although the 
differences were not statistically significant. Latency: mean difference of 2.70 ± 2.12 minutes (95%CI of -1.51 
minutes - 6.92 minutes). Duration: mean difference of -33 minutes 5 seconds ± 31 minutes (95% CI -1 hour 35 
minutes - 29 minutes).
There were 4 adverse events that did not require the patients to be withdrawn from the study.
Conclusions: The anaesthetics in this study have very similar properties for use in surgery and have demonstrated 
a good safety and tolerability profile.
Key words: Articaine, lidocaine, vasoconstrictor, adverse reactions.
Martínez-Rodríguez N, Barona-Dorado C, Martín-Arés M, Cortés-Bre-
tón-Brinkman J, Martínez-González JM. Evaluation of the anaesthetic 
properties and tolerance of 1:100,000 articaine versus 1:100,000 lido-
caine. A comparative study in surgery of the lower third molar. Med Oral 
Patol Oral Cir Bucal. 2012 Mar 1;17 (2):e345-51.   
 http://www.medicinaoral.com/medoralfree01/v17i2/medoralv17i2p345.pdf
Article Number: 17414          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed




Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17 (2):e345-51.                                                                                                                 Anaesthetic properties and tolerance of articaine and lidocaine
e346
Introduction
Lidocaine is currently the most studied local anaes-
thetic in dentistry. Its pharmacodynamic characteristics 
are the baseline in comparative studies with other local 
anaesthetics.
Currently, all of these have an amide bond that gives 
them their characteristic safety parameters for latency, 
potency and toxicity.
Articaine falls within this category, except that it con-
tains a thiophene ring within its chemical structure that 
gives it an increased solubility coefficient, resulting in 
faster diffusion over nerve structures (1).
The primary studies comparing articaine with other an-
aesthetics have primarily been performed in root canal 
surgery. References to oral surgery are even more scarce 
and primarily are concerned with tolerance (2-5).
The objectives of this study are to evaluate the anaes-
thetic properties and tolerance of articaine versus lido-
caine at equal vasoconstrictor concentration. 
Materials and Methods
This study, approved by the Clinical Trials Ethics Com-
mittee (EudraCT No “2006-00303170”), was designed 
as a parallel, simple blind, single-site study with ran-
domisation in four-element blocks or two treatments 
and was carried out in the Department of Medicine and 
Orofacial Surgery at the Complutense University of 
Madrid School of Dentistry. The study was open to the 
investigators and blind to the patients. 
A total of 96 male and female patients participated who 
underwent surgical treatment of the lower third molar. 
Patients were informed of the characteristics and objec-
tives of the study and Informed Consent was obtained. 
Additionally, the current and previous medical and den-
tal histories were obtained and compliance with the in-
clusion and exclusion criteria was established (Table 1). 
6 blocks of 4 possible treatments were established; 
Test-A and reference-B (Table 2). Treatment test-A used 
1:100,000 articaine hydrochloride with epinephrine, 
injectable solution, marketed by Normon Laborato-
ries S.A. under the brand name Ultracaine® (72 mg of 
articaine and 18 mg of epinephrine in 1.8 ml). Refer-
ence treatment-B used 1:100,000 lidocaine hydrochlo-
ride with epinephrine, injectable solution, marketed by 
Clarben Laboratories under the brand name Octocaine® 
(36 mg of lidocaine and 18 mg of epinephrine in 1.8 
ml).
Using the conventional nerve root technique, 1.8 ml of 
anaesthesia was administered to block the inferior al-
veolar nerve and the lingual nerve. Once the first signs 
of labial numbness appeared, anaesthesia of the buccal 
nerve by administering 0.9 ml from a second carpule. 
Those cases that required administration of higher 
quantities of anaesthetic were excluded from the study. 
For surgical treatment of the lower third molars, an an-
gular incision was made with mucoperiosteal detach-
ment, eliminating the osseous surface that covers the 
third molar. Once the third molar was removed, the mu-
INCLUSION 
• Male and female patients who provide their consent to participate in the study. 
• Age between 18 and 45 years of age. 
• Presence of retained lower third molar that is susceptible to surgical extraction. 
• Patients who are capable of understanding and carrying out the instructions given 
by the investigators. 
EXCLUSION 
• Women who are found to be pregnant or are nursing. 
• Patients with cardiovascular problems, renal and/or liver failure, and/or blood 
dyscrasias. 
• Patients with a history of hypersensitivity to the anaesthetics under study. 
• Patients with deformities that may interfere with the injections or evaluations. 
• Participation in another study with drugs that are under investigation in the 
previous 3 months. 
• Inability to follow the instructions or cooperate during the study.       
WITHDRAWAL 
Patients may withdraw their participation in the study at any time based on their 
own judgment. The investigators may decide to withdraw a participant from the 
study if they are not compliant with the rules of the protocol or if any of the 
following circumstances occur: 
• Need for a second dose of anaesthesia. 
• Onset of adverse reactions. 
Table 1. Selection of participants.
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coperiosteal flap was repositioned with 000 silk and the 
patients were instructed on the normal postoperative 
recommendations.
Monitoring of the variables analysed intra-operatively 
consisted of:
Evaluation of latency time. Period in minutes from the 
time of administration of the local anaesthetic until the 
onset of the sensation of labial numbness.
Evaluation of the duration of anaesthesia. Patients re-
corded the time at which the sensation of anaesthesia 
(numbness) disappeared in the lower lip in their case 
report forms (CRF).
In order to analyse tolerance of both anaesthetics and 
the possibility of adverse events during the study, the 
patients were evaluated intra- and postoperatively for 
the onset of adverse events. These were noted in the 
CRF and were reported spontaneously by the patients. 
Each adverse event was described based on the moment 
of onset, duration, intensity, course and outcome in or-
der to perform an evaluation of the causal relationship 
between the adverse effect and the medication. The in-
tensity was evaluated based on a three-level subjective 
scale (mild, moderate, severe). The possible relationship 
of the adverse events to the study medication was clas-
sified as definite, probable, possible, conditional or un-
related according to the Karch and Lasagna algorithm 
(6) (Table 3).
Based on the severity of the adverse reactions, when 
they occurred, they were classified as: severe – required 
continuous medical attention and/or loss of work; mod-
erate - required administration of additional medica-
tion; and mild – no additional treatment required. 
The onset of any suspected adverse reaction should be 
reported immediately to the study monitor and the cen-
tre’s Clinical Trials and Research Committee (CTRC, 
San Carlos Clinic, Madrid).
Statistically, the overall descriptive results were ex-
pressed, depending on their characteristics, as frequen-
cy tables or as mean values ± standard deviation.
The anaesthesia latency time and the duration was 
evaluated using the ANOVA test with a 95% confidence 
interval with the anaesthesia used as the independent 
variable.
Results
There were no significant differences in the duration of 
the intervention in those patients who received articaine 
or lidocaine (mean difference -10.69 seconds ± 1 minute 
4 seconds, 95%CI: -2 minutes 19 seconds - 1 minute 57 
seconds).
Regarding the differences in latency time, though it was 
faster in the case of articaine, the differences were not 
statistically significant (1.04 ± 0.7 minutes for articaine 
versus 3.75 ± 14.71 minutes for lidocaine, with a mean 
difference of 2.70 ± 2.12 minutes, 95% CI 1.51 minutes 
- 6.92 minutes (Fig. 1). 
The duration of the anaesthetic effect, recorded by pa-
tients after the disappearance of the sensation of numb-
ness in the lower lip, was also greater for articaine but 
the difference also was not statistically significant (4 
BLOCK 1 BLOCK 2 BLOCK 3 BLOCK 4 BLOCK 5 BLOCK 6
A A A B B B 
A B B B A A 
B B A A A B 
B A B A B A 
Evaluation of the causal relationship Definite Probable Possible Conditional
Not
related
Reasonable temporal sequence Yes Yes Yes Yes Yes or No 
Known response to the drug Yes Yes Yes No No 
Reaction improves upon suspension of the drug Yes Yes Yes or No Yes or No Not 
The reaction does not reoccur upon re-exposure Yes ? ? ? ? or No 
Alternative explanation for this reaction Not No Yes No Yes 
Table 2. Randomisation blocks. Method for assigning volunteers to each treatment group.
Table 3. Adverse events based on the Karch and Lasagna algorithm (6). 




















Fig. 1. Latency period for articaine versus lidocaine, expressed in minutes. 
Fig. 2. Time of anaesthesia duration for articaine versus lidocaine, expressed in minutes. 
    Articaine                                     Lidocaine
    Articaine                                            Lidocaine
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hours 6 minutes ± 2 hours 28 minutes for articaine, 
compared with 3 hours 33 minutes ± 2 hours 35 minutos 
for lidocaine, with a mean difference of -33 minutes 5 
seconds ± 31 minutes, 95% CI of -1 hour 35 minutes - 29 
minutes) (Fig. 2).
Regarding the appearance of adverse events during the 
study, there were only instances in 4 patients. All were 
documented in accordance with the rules established in 
the study protocol, were self-limiting, and did not re-
quire the volunteers to be excluded from the study (Ta-
ble 4).
One male patient suffered an episode of tachycardia fol-
lowed by hypotension and bradycardia with sweating 
(vagal syncope). The episode was mild in intensity, self-
limiting following administration of the drug (articaine) 
and resolved spontaneously. Initially, a causal relation-
ship to the drug was not assigned in the CRF. However, 
follow-up evaluation of the causal relationship to the 
study medication has been established as “probable”.
The second patient, a woman who belonged to the ar-
ticaine group, presented with facial oedema, pain and 
swelling in the right auricular region during the 7 days 
following the intervention, probably related to a local 
infectious process. This required a change in the antibi-
otic and an extension of treatment with anti-inflamma-
tory and analgesic medications. Initially, the causal re-
lationship was considered conditional and the intensity 
was considered moderate. 
None of the adverse effects that occurred during the 
study were severe and none required withdrawal of the 
patient.
Discussion
Lidocaine is probably the most widely-used anaesthesia 
in dentistry. Numerous clinical trials have been con-
ducted in which it has been compared to other amide 
anaesthetics (7-10). The model applied to evaluate the 
variables of this study corresponded to surgery of the 
lower third molars. Multiple studies that use articaine 
have been analysed but these do not analyse its level of 
efficacy (11-13).
The first variables studied in this investigation, latency 
time and duration of anaesthetic effect, acquire a cer-
tain level of relevancy in patients who undergo surgery 
and who also have a certain level of anxiety as the speed 
of anaesthetic onset and duration of anaesthetic effect 
provides greater peace of mind.
For the first variable, latency period, no statistically 
significant differences were seen between both anaes-
thetics, though articaine was faster in achieving the first 
signs of labial numbness. 
These results concur with those found by other authors, 
establishing a mean value for this variable of around 1.2 
– 2.5 minutes (14-16).
The duration of the anaesthetic effect also did not show 
any statistically significant differences, though greater 
duration times were seen for articaine. Authors such as 
Sierra et al. and Tofoli et al. (14-17) coincide with our 
results in establishing a mean interval of duration of ap-
proximately 245 minutes. However, the first of these, 
in their comparative study between articaine and lido-
caine, statistically significant differences were found in 
favour of articaine.
Regarding the appearance of adverse events, there are 
few specific studies and they are occasionally subject to 
interpretation. Malamed et al. (18), in a multisite study 
in patients between 4 and 80 years of age performed 
in 2000 on 882 individuals who were anesthetised with 
articaine versus 443 with lidocaine, established that ar-
ticaine, as with other amide anaesthetics, was safe and 
provided reliable anaesthesia during any dental treat-
ment.
In 2008, Adewumi et al. (19), studying a series of 204 
paediatric patients between 2 and 14 years of age, found 
the most common adverse effect to be injury to the lips 
due to biting. We confirm this effect, though it has not 
been the object of the study. In our opinion, we never 
recommend the use of articaine in child patients due to 
its prolonged anaesthetic effect on soft tissues, a situa-
tion that has been corroborated in our results.
We also have not found, in our experience nor in this 
study, temporary or permanent effect or injury to the 
inferior alveolar nerve as other authors have stated. We 
believe that these effects are difficult to attribute exclu-
sively to the anaesthetic effect and may be attributable 
to the traumatic effect of the anaesthesia needle itself. 
The study performed by Pogrel et al. (20) in 2007 is in-
teresting in that is established the same percentages for 





Tachycardia Mild Probable NR 
Vagal Syncope NR Probable NR 
Facial Oedema  Moderate Conditional Tx 
Right Ear Pain Moderate Conditional Tx 
Table 4. Adverse events. NR: Not recorded. Tx: treatment.
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The adverse events seen in this study were infrequent, 
of little consequence, and at no time required withdraw-
al of the patients.
The first of these, as has already been mentioned, de-
veloped a vagal response of rapid onset and rapid reso-
lution. When interpreting this finding, one should also 
take into account the anxiety factor that many patients 
suffer when they are to undergo dental treatment. How-
ever, probably more importantly, is that it is related to 
the surgical intervention. Oral surgery is one of the sur-
gical procedures that generates the greatest stress for 
patients. Additionally, the cardiovascular reactions that 
result from this situation of psychological stress vary 
between people and situations, which may produce car-
diac or peripheral vascular reactions (21-24).
The second patient persisted with oedema and pain for a 
longer period than normal. It is also evident that the tri-
ad of pain, inflammation and trismus is usually present 
following surgery of the lower third molars. There are 
numerous studies that state that the symptom of pain 
appears predominantly between 6 and 12 hours follow-
ing surgery, though it may be mild during the first 48 
hours. The inflammatory process is more prolonged, 
reaching 96 hours (25-27). 
The persistence of these symptoms beyond the expected 
time must be interpreted as a sign of active infection 
and therefore we should question the efficacy of the an-
tibiotic treatment being administered. This is the cir-
cumstance that required us to change from amoxicillin 
to clindamycin in our case. This patient’s reaction was 
controlled at 10 days, returning the progression back to 
normal. This event was classified as conditional because 
this occurred during a clinical trial and, as a result, one 
is required to record any event that occurs in the CRF.
In summary, we can state that both articaine and lido-
caine have demonstrated and adequate and similar 
safety and tolerability profile. For this reason, their use 
in oral surgery should remain at the discretion of the 
professional who will evaluate their use based on the 
necessary surgical time.
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